P. Rigo

Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging

Guy Jérusalem, Yves Béguin, Marie France Fassotte et al. · Blood · 1999 · 556 citations

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

Thierry Bury, Ana Terra Fonseca Barreto, Frédéric Daenen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1998 · 315 citations · Full text

Positron Emission Tomography, Bone Imaging, Engineering +12

Value, sensitivity and specificity of stroke volume ratio in routine equilibrium gated scintigraphy

P. Gobert, René Kremer, P. Rigo et al. · European Heart Journal · 1987 · 297 citations

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)

Guy Jérusalem, Yves Béguin, Fadi Najjar et al. · Annals of Oncology · 2001 · 268 citations

Positron Emission Tomography, Lymphoid Neoplasia, Oncologic Imaging +9

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

Guy Jérusalem, Yves Béguin, Marie France Fassotte et al. · Annals of Oncology · 2002 · 213 citations

Positron Emission Tomography, Medical Imaging, Diagnosis +7